Younger patients with metastatic colorectal cancer show advanced disease but longer survival
Medical Xpress1 min read76 words
Metastatic colorectal cancer (mCRC) is increasingly affecting patients aged 45 and younger, a trend highlighted by new study findings. These younger patients present with more advanced disease compared to their older counterparts, yet they demonstrate longer survival rates.
The distinct disease patterns and improved outcomes observed in this younger demographic suggest a need for heightened clinical attention. Specifically, the findings indicate that closer scrutiny of gastrointestinal symptoms may be warranted for individuals in this age group.
Read the original at Medical Xpress
🤖 AI-generated content — This article was automatically summarised from public RSS feeds by AutoBrief. Verify important information with the original source.